Literature DB >> 11477537

Naive CD4(+) lymphocytes convert to anergic or memory-like cells in T cell-deprived recipients.

C Tanchot1, A Le Campion, S Léaument, N Dautigny, B Lucas.   

Abstract

Recent demonstrations that naive T cells proliferate after transfer to lymphopenic hosts have led to the theory that active homeostatic mechanisms fill the peripheral pool of naive T cells. To extend these data, we injected naive CD4(+) T cells from AND TCR transgenic mice (H-2(b/b) or H-2(k/k)) into CD3 epsilon-deficient mice, and studied the absolute number, phenotype and functional capacities of the transferred lymphocytes, from the first days to a few months after transfer. Proliferation of naive CD4(+) T cells did not fill the peripheral naive T cell pool. Injected naive T cells acquired a memory-like phenotype that was stable with time, despite the absence of foreign antigenic stimulation. Their functional capacities were modified, enhanced or abolished depending on the MHC haplotype. Thus, "homeostatic" proliferation of naive CD4(+) T cells in T cell-deprived recipients does not regenerate the naive CD4(+) T cell pool.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11477537     DOI: 10.1002/1521-4141(200108)31:8<2256::aid-immu2256>3.0.co;2-8

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  16 in total

Review 1.  The concept of space and competition in immune regulation.

Authors:  Brigitta Stockinger; Thomas Barthlott; George Kassiotis
Journal:  Immunology       Date:  2004-03       Impact factor: 7.397

Review 2.  Innate memory T cells.

Authors:  Stephen C Jameson; You Jeong Lee; Kristin A Hogquist
Journal:  Adv Immunol       Date:  2015-02-07       Impact factor: 3.543

3.  Control of homeostatic proliferation by regulatory T cells.

Authors:  Shiqian Shen; Yi Ding; Carlos E Tadokoro; Danyvid Olivares-Villagómez; Marlin Camps-Ramírez; Maria A Curotto de Lafaille; Juan J Lafaille
Journal:  J Clin Invest       Date:  2005-11-17       Impact factor: 14.808

4.  In vivo expansion of CD4CD45RO-CD25 T cells expressing foxP3 in IL-2-treated HIV-infected patients.

Authors:  Irini Sereti; Hiromi Imamichi; Ven Natarajan; Tomozumi Imamichi; Meena S Ramchandani; Yunden Badralmaa; Steve C Berg; Julia A Metcalf; Barbara K Hahn; Jean M Shen; April Powers; Richard T Davey; Joseph A Kovacs; Ethan M Shevach; H Clifford Lane
Journal:  J Clin Invest       Date:  2005-06-02       Impact factor: 14.808

5.  Quantitative analysis of T cell homeostatic proliferation.

Authors:  Cheng-Rui Li; Sharon Santoso; David D Lo
Journal:  Cell Immunol       Date:  2008-03-03       Impact factor: 4.868

6.  Impact of T cell selection methods in the success of clinical adoptive immunotherapy.

Authors:  Natalia Ramírez; Lorea Beloki; Miriam Ciaúrriz; Mercedes Rodríguez-Calvillo; David Escors; Cristina Mansilla; Eva Bandrés; Eduardo Olavarría
Journal:  Cell Mol Life Sci       Date:  2014-04       Impact factor: 9.261

7.  Naive T cells proliferate strongly in neonatal mice in response to self-peptide/self-MHC complexes.

Authors:  Armelle Le Campion; Christine Bourgeois; Florence Lambolez; Bruno Martin; Sandrine Léaument; Nicole Dautigny; Corinne Tanchot; Claude Pénit; Bruno Lucas
Journal:  Proc Natl Acad Sci U S A       Date:  2002-03-26       Impact factor: 11.205

8.  Depletion and recovery of lymphoid subsets following morphine administration.

Authors:  E Y Zhang; J Xiong; B L Parker; A Y Chen; P E Fields; X Ma; J Qiu; T M Yankee
Journal:  Br J Pharmacol       Date:  2011-12       Impact factor: 8.739

Review 9.  Antigen-dependent and -independent mechanisms of T and B cell hyperactivation during chronic HIV-1 infection.

Authors:  Anna Haas; Kathrin Zimmermann; Annette Oxenius
Journal:  J Virol       Date:  2011-08-17       Impact factor: 5.103

10.  A conserved CXXC motif in CD3epsilon is critical for T cell development and TCR signaling.

Authors:  Yibing Wang; Dean Becker; Tibor Vass; Janice White; Philippa Marrack; John W Kappler
Journal:  PLoS Biol       Date:  2009-12-01       Impact factor: 8.029

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.